The fund’s strategy is to invest in a variety of AI companies with radiology solutions in order to create diversified access to this sector. The managing partners believe that investing in a diverse portfolio is more likely to yield profitable outcomes and be less risky than investing in a single venture. Bold Brain Ventures is targeting a $25MM fund size with a first close of $1MM and a maximum size of $100MM. The fund is capped at 99 investors per SEC regulations. Those who are interested in investing can register for free on a secure online portal at www.boldbrainventures.com to view potential opportunities and track investments.
Dr. Deur says, “Physicians would be wise to consider how they can help proactively advance AI in medicine and involve themselves in this changing landscape.”
Dr. Prasad continues, “The future is here...now is the right time to immerse yourself in AI.”
Bold Brain Ventures was formed in Pittsburgh, Pennsylvania. The fund opened for investment in October 2018. It is a Rule 506(c) offering under Regulation D of the SEC. The founders and Managing Partners of the company are Tomislav Deur, MD and Robin Prasad, MD, MS, MBA. Dr. Deur and Dr. Prasad are board-certified practicing radiologists with investment expertise. They have a 20-year history of working together successfully in the healthcare field and other endeavors. Paige Creo, MBA is the Vice President of Strategy & Marketing. She has 8+ years of marketing and strategy experience, and she has been working with Bold Brain Ventures since the inception of the company.
Bold Brain Ventures will be exhibiting for the first time at Booth 6072 in the Machine Learning Showcase at the RSNA 2018 Annual Meeting Conference.
Back to HCB News
